Skip to main content

Find Clinical Trials

Home
Conditions
EGFR Mutation-negative and ALK Rearrangement-negative

Clinical trial condition

EGFR Mutation-negative and ALK Rearrangement-negative

Explore clinical trials studying EGFR Mutation-negative and ALK Rearrangement-negative. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

EGFR Mutation-negative and ALK Rearrangement-negative trial results

Recruiting

Efficacy and Safety of Ivonescimab Monotherapy as First-Line Treatment for PD-L1-Positive, Driver Gene-Negative, Locally Advanced or Metastatic NSCLC: A Multicenter, Prospective, Real-World Cohort Study

NCT07696832

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
Locations: Guangdong Provincial People's Hospital Guangzhou, Guangdong, China

View Trial Details